Bibliographie - 4112 - Stabilis 4.0

Siste oppdatering :
18/04/2024

Referanser 4112

Type :

Journal

Internett-koblingen :

https://ijpc.com/Abstracts/Abstract.cfm?ABS=4458

Forskerteamet :

Auckland - Faculty of Medical and Health Sciences, University of Auckland

Forfattere :

Svirskis D, Lin S.W, Brown H, Sangaroothong A, Wang Z, Xu H, Dean R, Vareed P, Jensen M, Wu Z.

Tittel :

The Influence of Tablet Formulation, Drug Concentration, and pH Modification on the Stability of Extemporaneously Compounded Levothyroxine Suspensions.

Nummer :

Int J Pharm Compound ;22,2:164-171 2018

Nivå of Evidence :

Fysisk stabilitet :

Kjemisk stabilitet :

Andre metoder :

Kommentarer :

Lister

Levothyroxine

1,5 mg
Eltroxin®

Glyserin
Renset vann	>> 100 mL

22°C

1,5 mg
® = Levothyroxine Mercuri Pharma

Glyserin
Renset vann	>> 100 mL

22°C

1,5 mg
Eltroxin®

Glyserin
Renset vann	>> 100 mL

4°C

1,5 mg
® = Levothyroxine Mercuri Pharma

Glyserin
Renset vann	>> 100 mL

4°C

Mentions Légales